medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 4

<< Back Next >>

Acta Pediatr Mex 2017; 38 (4)

Infant hypertensive emergency secondary to autosomic recessive polycystic kidney disease. Case report

Quisbert-Cruz R, Zárate-Mondragón F
Full text How to cite this article

Language: Spanish
References: 12
Page: 237-243
PDF size: 423.19 Kb.


Key words:

polycystic kidney disease, congenital liver disease, hypertensive emergency, ductal plate.

ABSTRACT

Polycystic kidney disease associated with congenital hepatic fibrosis is an inherited disease; it is within the spectrum of diseases hepatorenal fibrocystic. Its estimated frequency is 1 in 20,000 live births for the variety of autosomal recessive polycystic kidney disease and rarer for autosomal dominant variety. One case report is presented about a patient whose illness began with a difficult control hypertensive crisis arises due to polycystic kidney disease and congenital hepatic fibrosis, a rare clinical presentation. Include the importance of controlling blood pressure to prevent complications due to high blood pressure as cardiac hypertrophy, heart failure and chronic retinopathy.


REFERENCES

  1. Jonas MM, Pérez-Atayde AR. Fibrocystic liver disease; In: Suchy FJ, Spkol RJ, Balistreri WF, editors. Liver Disease in Children. 3th. New York, USA: Cambridge University Press. 2007. pp. 928-42.

  2. Saraga-Babić M, Vukojević K, Bočina I. Ciliogenesis in normal human kidney development and post-natal life. Pediatr Nephrol. 2012;27:55–63.

  3. Park E, Lee JM, Ahn YH. Hepatorenal fibrocystic diseases in children. Pediatr Nephrol. 2016;31:113-9.

  4. Rock N, McLin V. Liver involvement in children with ciliopathies. Clin Res Hepatol Gast. 2014;38:407-14.

  5. Saraga-Babić M, Vukojević K, Bočina I, Drnašin C, Saraga M. Ciliogenesis in normal human kidney development and post-natal life. Pediatr Nephrol 2012;27:55-63.

  6. Turkbey B, Ocak I, Daryanani K, Font-Montgomery E, Lukose L, Bryant J, et al. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF). Pediatr Radiol. 2009;39:100-11.

  7. Sweeney WE, Avner ED. Polycystic Kidney Disease, Autosomal Recessive. 2001. In: Pagon RA, Adam MP, Ardinger HH, et al., ed. Gene Reviews Seattle: University of Washington, Seattle. pp. 1993-2016.

  8. Drenth J, Chrispijn M, Bergmann C. Congenital fibrocystic liver diseases. Best practice & research. Clin Gastroent. 2010;24:573–84.

  9. Gunay-Aygun M, Avner ED, Bacallao RL. Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/office of rare diseases conference. J Pediatr. 2006;149:159-64.

  10. Nazer D, Nazer HM. Congenital Hepatic Fibrosis. DOI 10.1007/978-3-642-02202-9_208.

  11. Ariceta G, Lens XM. Poliquistosis renal autosómica recesiva. Nefrol2003;1:23-8.

  12. Roy S, Dillon MJ, Trompeter RS. Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Ped Nephro. 1997;11:302–6.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2017;38